• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Andrea Bullock, MD


  • Zwicker JI, Liebman HA, Bauer KA, Caughey T, Campigotto F, Rosovsky R, Mantha S, Kessler CM, Eneman J, Raghavan V, Lenz HJ, Bullock A, Buchbinder E, Neuberg D, Furie B.Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study).British Journal of Haematology. 2013 Feb;160(4):530-7.
  • Bullock AJ, Hofstatter EW, Yushak ML, Buss MK.Understanding patients' attitudes toward communication about the cost of cancer care.J Oncol Pract. 2012 Jul;8(4):e50-8.
  • Mahadevan A, Miksad R, Goldstein M, Sullivan R, Bullock A, Buchbinder E, Pleskow D, Sawhney M, Kent T, Vollmer C, Callery M.Induction Gemcitabine and Stereotactic Body Radiotherapy for Locally Advanced Nonmetastatic Pancreas Cancer.Int J Radiat Oncol Biol Phys. 2011 Jun 8.
  • Bullock A, McDermott DF, Atkins MB.Management of metastatic renal cell carcinoma in patients with poor prognosis.Cancer Management and Research. 2010;2:123-32.
  • Curhan GC, Bullock AJ, Hankinson SE, Willett WC, Speizer FE, Stampfer MJ.Frequency of use of acetaminophen, nonsteroidal anti-inflammatory drugs, and aspirin in US women.Pharmacoepidemiol Drug Saf. 2002 Dec;11(8):687-93.